Company Prelude Therapeutics Incorporated
Equities
PRLD
US74065P1012
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.07 USD | +0.74% | +9.41% | -4.68% |
Business Summary
Number of employees: 128
Managers
Managers | Title | Age | Since |
---|---|---|---|
Krishna Vaddi
FOU | Founder | 58 | 16-01-31 |
Bryant Lim
DFI | Director of Finance/CFO | 53 | 23-01-31 |
Jane Huang
PSD | President | 51 | 22-04-03 |
Wan-Jen Hong
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Madhu Pudipeddi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aimee Crombie
COO | Chief Operating Officer | - | 17-12-31 |
Peggy Scherle
CTO | Chief Tech/Sci/R&D Officer | 62 | 18-03-31 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Michele Porreca
HRO | Human Resources Officer | - | 21-05-31 |
Andrew Combs
PRN | Corporate Officer/Principal | 58 | 19-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 21-01-24 |
Paul Friedman
CHM | Chairman | 81 | 16-06-30 |
David Bonita
BRD | Director/Board Member | 48 | 16-06-30 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-07-31 |
Martin Babler
BRD | Director/Board Member | 59 | 21-07-18 |
Victor Sandor
BRD | Director/Board Member | 57 | 20-04-30 |
Krishna Vaddi
FOU | Founder | 58 | 16-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,920,594 | 51,116,607 ( 93.07 %) | 0 | 93.07 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.68% | 223M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PRLD Stock
- Company Prelude Therapeutics Incorporated